Case study report of two palliative care patients receiving intracerebroventricular (ICV) analgesia.
D000328:Adult; D000368:Aged; D000698:Analgesia / Q000379:methods* / Q000523:psychology; D000701:Analgesics, Opioid / Q000008:administration & dosage; D001859:Bone Neoplasms / Q000150:complications / Q000556:secondary; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D017809:Fatal Outcome; D006801:Humans; D007276:Injections, Intraventricular; D008175:Lung Neoplasms / Q000150:complications / Q000556:secondary; D008297:Male; D017599:Neuroectodermal Tumors / Q000150:complications / Q000556:secondary; D010146:Pain / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D010147:Pain Measurement; D010166:Palliative Care / Q000379:methods* / Q000523:psychology; D011471:Prostatic Neoplasms / Q000150:complications / Q000556:secondary; D011788:Quality of Life; D013125:Spinal Neoplasms / Q000150:complications / Q000556:secondary; D016896:Treatment Outcome; D014696:Ventriculostomy / Q000379:methods* / Q000523:psychology
D000701:Analgesics, Opioid